Safety and efficacy of L-carnitine supplementation in patients with hematopoietic stem cell transplantation

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2013
INTERVENTION: L‐carnitine supplementation No carnitine supplementation CONDITION: Hematological malignancy, Bone marrow failure syndrome PRIMARY OUTCOME: The change in average fatigue from baseline to day100 INCLUSION CRITERIA: Eligibility criteria included 20 years of age or older. All patients need possiblility of survival of more than 3 months from the time of registration and written informed consent.
Epistemonikos ID: aabb61a5b6a1ad61a343d6c9e2340eb3d182fb18
First added on: Aug 22, 2024